An, XuefengUniversität HeidelbergHeidelberg
Refine publication list
Year of publication
Type of Publication
Language
Co-author (Univ. of Heidelberg)
Publications in heiBIB 
- Liu, Li: Corrigendum to “Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of cell death” [Biomed. Pharmacother. 153 (2022) 113511] / Li Liu, XueFeng An, Michael Schaefer, Bin Yan, Carolina de la Torre, Stefan Hillmer, Jury Gladkich, … , 31 December 2023. - 2 S. : Illustrationen
In: Biomedicine & pharmacotherapy, ISSN 1950-6007. 169(2023), Seite 1-2
DOI: 10.1016/j.biopha.2023.115879
- Liu, Li: Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of cell death / Li Liu, XueFeng An, Michael Schaefer, Bin Yan, Carolina de la Torre, Stefan Hillmer, Jury Gladkich, … , 2 August 2022. - 18 S. : Illustrationen, Graphen
In: Biomedicine & pharmacotherapy, ISSN 1950-6007. 153(2022), Artikel-ID 113511, Seite 2-18
DOI: 10.1016/j.biopha.2022.113511
- An, Xuefeng: α-lipoic acid prevents side effects of therapeutic nanosilver without compromising cytotoxicity in pacreatic cancer / vorgelegt von Xuefeng An ; Doktormutter: Prof. Dr. rer. nat. Ingrid Herr. -
Heidelberg, 2021. - 106 Blätter : Illustrationen, Diagramme
- An, Xuefeng: Alpha-lipoic acid prevents side effects of therapeutic nanosilver without compromising cytotoxicity in experimental pancreatic cancer / Xuefeng An, Li Liu, Michael Schaefer, Bin Yan, Christian Scholz, Stefan Hillmer, Kangtao Wang, Yiqia… , 24 September 2021. - 26 S.
In: Cancers, ISSN 2072-6694. 13(2021), 19, Artikel-ID 4770, Seite 1-26
DOI: 10.3390/cancers13194770
- Luo, Yiqiao: Sulforaphane inhibits the expression of long noncoding RNA H19 and its target APOBEC3G and thereby pancreatic cancer progression / Yiqiao Luo, Bin Yan, Li Liu, Libo Yin, Huihui Ji, Xuefeng An, Jury Gladkich, Zhimin Qi, Carolina De … , 16 February 2021. - 23 S.
In: Cancers, ISSN 2072-6694. 13(2021), 4, Artikel-ID 827, Seite 1-23
DOI: 10.3390/cancers13040827
